What is the global market size of Nutritional Immunology Market?

Nutritional Immunology Market was valued at USD 55.45 billion in 2021, and USD 56.2 Billion in 2022 and the market size is estimated to reach USD 116.80 billion by 2030, at a CAGR of 11.8% over the forecast period (2023-2030).

Nutritional Immunology Market Size, Share, Growth Analysis, By Ingredient Type(Vitamins, Minerals, Herbal Botanical Extracts, Probiotics), By Form(Soft Gels/Capsules, Tablets, Powder, Liquids), By Source Type(Plant-Based, Animal-Based), By Distribution Channel(Pharmacies, Drug Stores, Hypermarket/Supermarket, Online Stores), By Region - Industry Forecast 2024-2031

Report ID: SQSG30I2048 | Region: Global | Published Date: July, 2001
Pages: 245 | Tables: 125 | Figures: 73

Nutritional Immunology Market Competitive Landscape

Nutritional Immunology Market Top Players Company Profiles

Bayer AG (Germany)
Pfizer Inc. (US)
Sun Pharmaceutical Industries Limited (India)
Swisse Wellness Pty Ltd. (Australia)
GlaxoSmithKline Inc. (UK)
Abbott Laboratories (US)
Amway Corp. (US)
The Nature's Bounty Co. (US)
Herbalife Nutrition of America, Inc. (US)
Himalaya Global Holdings Ltd. (India)
American Health (US)
Unilever (UK)
Sanofi (France)
Novartis (Switzerland)
Boehringer Ingelheim (Germany)
Nestlè (Switzerland)

Nutritional Immunology Market Recent Development

In March 2022, Pura Collagen introduced a new supplement which aims to provide immune support for consumers.
In July 2021, Solabia-Algatech Nutrition announced the launch of BioGlena powdered ingredients for immune support. The company is strategically looking to increase our microalgae portfolio and meet the increased demand for immune-supporting and clean label ingredients.

Nutritional Immunology Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Nutritional Immunology Market was valued at USD 55.45 billion in 2019, and USD 56.2 Billion in 2019 and the market size is estimated to reach USD 116.80 billion by 2031, at a CAGR of 11.8% over the forecast period (2024-2031).

Key companies are primarily focusing on new product invention and development. For instance, in April 2019, Bayer AG developed a new approach on triple-action supplement to combat immunity issues during the Ramadan fasting period. Abbott released a new Pedialyte hydration product to enhance immunological health in December 2020. Pedialyte with Immune Support contains prebiotics, vitamin B12, vitamin C, vitamin E, and zinc, all of which have been specifically chosen for their role in immune system support. 'Bayer AG (Germany)', 'Pfizer Inc. (US)', 'Sun Pharmaceutical Industries Limited (India)', 'Swisse Wellness Pty Ltd. (Australia)', 'GlaxoSmithKline Inc. (UK)', 'Abbott Laboratories (US)', 'Amway Corp. (US)', 'The Nature's Bounty Co. (US)', 'Herbalife Nutrition of America, Inc. (US)', 'Himalaya Holdings Ltd. (India)', 'American Health (US)', 'Unilever (UK)', 'Sanofi (France)', 'Novartis (Switzerland)', 'Boehringer Ingelheim (Germany)', 'Nestlè (Switzerland)'

For manufacturers, innovation has been a consistent component of the growth of the immune supplement market, as well as possibilities and corporate expansion. New product introductions that offer a variety of health advantages are driving greater demand for new immune supplement solutions. Furthermore, factors such as an increase in the use of conventional and new substances for supplement manufacture are driving the development of new revolutionary immune boosters. The elevated risk of infectious illnesses has also sparked interest in the creation of cutting-edge and novel immune health supplements.

The increasing frequency of chronic illnesses and other problems in senior individuals is likely to boost the worldwide immune health supplement market growth. Due to the rising incidence of chronic illnesses and other ailments among the senior population, the immune health supplements market is likely to increase significantly over the forecast period. According to a World Health Organization estimate from September 2019, around 50 million people worldwide have dementia, with nearly 10 million new cases diagnosed each year. According to the same source, Alzheimer's disease is the most prevalent kind of dementia, accounting for 60-70% of all cases.

North America led the market in 2021, accounting for the largest revenue share of 37.1%. The largest customer base for immune health supplements and rising individual awareness are expected to drive regional growth in the nutritional immunology market over the forecast years. Furthermore, a rising trend in the United States population to spend in preventative supplements is likely to boost market expansion in this region.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Nutritional Immunology Market Competitive Landscape

Nutritional Immunology Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Nutritional Immunology Market?

Who are the key vendors in the Nutritional Immunology Market?

What is the key driver of Nutritional Immunology Market?

What is the key market trend for Nutritional Immunology Market?

Which region accounted for the largest share in Nutritional Immunology Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300